However, it has been reported that the new PTX-3 biomarker was significantly increased in inflammation due to lung cancer, and in inflammatory diseases.16-19 In our study, posterolateral thoracotomy was performed in 11 patients due to lung cancer, intrapericardial pneumonectomy in two patients, sleeve lobectomy in one patient, bilobectomy in one patient, and lobectomy in seven patients; lymph node dissection was performed in all patients. The gene discussed is PTX3; the disease is lung carcinoma.